AU7392696A - Compounds, compositions and methods for inhibiting the binding of proteins containing an sh2 domain to cognate phosphorylated proteins - Google Patents

Compounds, compositions and methods for inhibiting the binding of proteins containing an sh2 domain to cognate phosphorylated proteins

Info

Publication number
AU7392696A
AU7392696A AU73926/96A AU7392696A AU7392696A AU 7392696 A AU7392696 A AU 7392696A AU 73926/96 A AU73926/96 A AU 73926/96A AU 7392696 A AU7392696 A AU 7392696A AU 7392696 A AU7392696 A AU 7392696A
Authority
AU
Australia
Prior art keywords
proteins
inhibiting
domain
binding
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73926/96A
Inventor
Elizabeth A. Lunney
Kimberly Suzanne Para
Mark Stephen Plummer
Josyula Venkata Nagendra Vara Prasad
Alan Robert Saltiel
Tomi Sawyer
Aurash Shahripour
Juswinder Singh
Charles John Stankovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of AU7392696A publication Critical patent/AU7392696A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/12—Esters of phosphoric acids with hydroxyaryl compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3834—Aromatic acids (P-C aromatic linkage)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3882—Arylalkanephosphonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4075—Esters with hydroxyalkyl compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU73926/96A 1995-10-04 1996-10-02 Compounds, compositions and methods for inhibiting the binding of proteins containing an sh2 domain to cognate phosphorylated proteins Abandoned AU7392696A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US495495P 1995-10-04 1995-10-04
US004954 1995-10-04
PCT/US1996/015998 WO1997012903A1 (en) 1995-10-04 1996-10-02 Compounds, compositions and methods for inhibiting the binding of proteins containing an sh2 domain to cognate phosphorylated proteins

Publications (1)

Publication Number Publication Date
AU7392696A true AU7392696A (en) 1997-04-28

Family

ID=21713373

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73926/96A Abandoned AU7392696A (en) 1995-10-04 1996-10-02 Compounds, compositions and methods for inhibiting the binding of proteins containing an sh2 domain to cognate phosphorylated proteins

Country Status (3)

Country Link
AU (1) AU7392696A (en)
WO (1) WO1997012903A1 (en)
ZA (1) ZA968334B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207397B1 (en) 1996-04-18 2001-03-27 Ariad Pharmaceuticals, Inc. In vitro fluorescence polarization assay
WO1999024442A1 (en) * 1997-11-12 1999-05-20 Ariad Pharmaceuticals, Inc. Novel signal transduction inhibitors, compositions containing them
EP1045836B1 (en) * 1997-12-18 2008-03-05 Boehringer Ingelheim Pharmaceuticals Inc. Pyridones as src family sh2 domain inhibitors
US6156784A (en) * 1997-12-18 2000-12-05 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as phosphotyrosine mimics
US6780609B1 (en) 1998-10-23 2004-08-24 Genome Therapeutics Corporation High bone mass gene of 1.1q13.3
US6770461B1 (en) 1998-10-23 2004-08-03 Genome Therapeutics Corporation High bone mass gene of 11q13.3
EP1064289A1 (en) * 1998-03-18 2001-01-03 Ariad Pharmaceuticals, Inc. Heterocyclic signal transduction inhibitors, compositions containing them
EP1129068A1 (en) 1998-11-12 2001-09-05 Ariad Pharmaceuticals, Inc. Bicyclic signal transduction inhibitors, composition containing them and uses thereof
EP1163262B1 (en) * 1999-03-23 2011-05-11 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Phenylalanine derivatives
FR2793796A1 (en) * 1999-04-14 2000-11-24 Hoechst Marion Roussel Inc Imidazole derivatives having Src SH2 receptor antagonist activity for the prevention and treatment of osteoporosis, auto-immune diseases, proliferative diseases, cancers, allergies and other disorders
FR2796381A1 (en) * 1999-07-12 2001-01-19 Hoechst Marion Roussel Inc Thiazepin and caprolactam bicyclic derivatives, useful in the treatment of e.g. osteoporosis and other bone disorders, infections, allergies or cancers
CN1454256A (en) * 2000-04-05 2003-11-05 基因组治疗公司 The high bone mass gene of 11q13.3
US6977241B2 (en) * 2000-08-22 2005-12-20 The United States Of America As Represented By The Department Of Health & Human Services SH2 domain binding inhibitors
US7425537B2 (en) 2000-08-22 2008-09-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services SH2 domain binding inhibitors
US7514594B2 (en) 2001-05-11 2009-04-07 Wyeth Transgenic animal model of bone mass modulation
AU2002308681A1 (en) 2001-05-11 2002-11-25 Wyeth Transgenic animal model of bone mass modulation
US20040038860A1 (en) 2002-05-17 2004-02-26 Allen Kristina M. Reagents and methods for modulating dkk-mediated interactions
US7098241B2 (en) 2002-12-16 2006-08-29 Hoffmann-La Roche Inc. Thiophene hydroxamic acid derivatives
WO2005050206A2 (en) * 2003-09-17 2005-06-02 Molecular Probes, Inc. Competitive immunoassay
ES2710617T3 (en) 2010-04-21 2019-04-26 Signature Therapeutics Inc Compositions comprising enzymatically cleavable amphetamine prodrugs and inhibitors thereof
AU2014262621B2 (en) 2013-05-08 2018-03-01 Baylor College Of Medicine STAT6 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU606808B2 (en) * 1988-06-29 1991-02-14 Otsuka Pharmaceutical Factory, Inc. Arylcarboxamide substituted by alkylphosphonates, process for preparing the same and a pharmaceutical composition containing the same
ES2064101T3 (en) * 1990-04-02 1995-01-16 Pfizer THYROSINE KINASE INHIBITORS BENZYLPHOSPHONIC ACID COMPOUNDS.

Also Published As

Publication number Publication date
ZA968334B (en) 1997-05-13
WO1997012903A1 (en) 1997-04-10

Similar Documents

Publication Publication Date Title
AU7392696A (en) Compounds, compositions and methods for inhibiting the binding of proteins containing an sh2 domain to cognate phosphorylated proteins
AU4915796A (en) Inhibitors of prenyl transferases
AU1719499A (en) Pyridones as src family sh2 domain inhibitors
AU6613996A (en) Heterocyclic compounds and pharmaceutical compositions containing them
AU5922096A (en) Methods and compositions for inhibiting 5alpha-reductase act ivity
EP0871444A4 (en) 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
AU5674696A (en) Compounds that bind to p185 and methods of using the same
AU6489396A (en) Methods of making viscoelastic compositions
AU4851397A (en) Compositions for the preparation of leather
AU2872795A (en) Inhibition of platelet binding
AU6856496A (en) Compositions and methods for inhibiting corrosion
AU7529096A (en) Substituted aryl pyrroles, compositions containing such compounds and methods of use
AU6485996A (en) Methods and compositions for modulation and inhibition of teomerase
AU2243797A (en) Methods and compositions for inhibiting hexokinase
AU4479096A (en) 5-methanesulfonamido-3h-isobenzofuran-1-ones as inhibitors of cyclooxygenase-2
AU3217595A (en) Stabilized compositions containing hemoglobin
AUPN933396A0 (en) Non-aqueuos oral-drench compositions containing avermectin compounds
AU8394698A (en) Film-forming compositions
AU5536599A (en) Process for the preparation of neotame
AU7986098A (en) 9a-aza-3-ketolides, compositions containing such compounds and methods of treatment
AU3731595A (en) Improved process for the preparation of 5-aminotetrazole
AU4622896A (en) Pharmaceutical composition for parenteral application containing an indole-carboxylic acid
AU7606396A (en) Method of improving the photostability of polypropylene compositions
AU4633397A (en) Synthesis of phosphorus compounds
AU6405596A (en) Use of stat 5 sh2 domain specific compounds to enhance erythropoiesis